Brazil’s chief well being regulator on Tuesday stated President Jair Bolsonaro’s previous skepticism about COVID-19 vaccines contradicts his company’s place and public statements, stressing the necessity immunize the inhabitants to include the pandemic.
Testifying earlier than a Senate committee investigating the Brazilian federal authorities’s dealing with of the COVID-19 well being disaster, Antonio Barra Torres, head of well being regulator Anvisa, additionally disagreed with Bolsonaro on masks and social distancing.
“We perceive, opposite to what you simply learn, that the vaccination coverage is important,” he instructed a senator asking about Bolsonaro’s previous public remarks downplaying the usefulness of vaccines.
Torres additionally stated he differs from the president relating to use of chloroquine, a malaria drug Bolsonaro has promoted as a COVID-19 remedy regardless of scientific research displaying that it’s
Concerning the company’s evaluation of Russia’s Sputnik V COVID-19, which isn’t accredited in Brazil, Torres stated the method is stalled pending arrival of paperwork requested from its native manufacturing companion Uniao Química (UQFN.UL).
Our Requirements: The Thomson Reuters Trust Principles.